FINANCIAL RESULTS
2022-02-04LL
Fourth quarter and full year 2021 results
Fourth quarter and full-year 2021 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Featuring
-
Paul Hudson
Chief Executive Officer -
Jean-Baptiste de Chatillon
Chief Financial Officer -
Bill Sibold
Specialty Care -
Thomas Triomphe
Vaccines -
Olivier Charmeil
General Medicines -
Julie van Ongevalle
Consumer Healthcare -
John Reed
R&D -
Roy Papatheodorou
General Counsel
Highlights
"Our performance in 2021 was impressive, across the business and in our scientific results. We are poised for success ahead."
Paul Hudson, CEO at Sanofi